Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma
Status:
Recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to determine if intervening with combined local therapy and
chemotherapy prior to chemotherapy alone in patients with oligorecurrent and oligometastatic
esophageal squamous cell carcinoma led to significant improvements in progression-free
survival (PFS).